(CCRN) Cross Country Healthcare - Ratings and Ratios

Cross Country Healthcare, Inc. is a leading provider of talent management services to the US healthcare industry, operating through two key segments: Nurse and Allied Staffing, and Physician Staffing. The company offers a comprehensive range of staffing solutions, including temporary and permanent placements, recruiting, and value-added total talent management services. Its Nurse and Allied Staffing segment caters to the needs of healthcare providers, offering staffing solutions for various professionals, including registered nurses, licensed practical nurses, and allied professionals, as well as workforce solutions such as MSP, VMS, RPO, and project management services. The Physician Staffing segment provides physicians and other medical professionals on temporary assignments to healthcare facilities, medical group practices, and managed care organizations.

The companys diverse client base includes public and private acute care and non-acute care hospitals, government facilities, healthcare plans, managed care providers, and other healthcare providers. With a strong presence in the US healthcare staffing market, Cross Country Healthcare has established itself as a trusted partner for healthcare providers seeking to address their staffing needs. The companys expertise in providing staffing solutions and talent management services enables healthcare providers to focus on delivering high-quality patient care.

Analyzing the and of CCRN, we can observe that the stock is currently trading at $14.01, slightly above its 20-day SMA of $13.90. The 50-day SMA and 200-day SMA are at $14.77 and $15.02, respectively, indicating a potential resistance level. The ATR of 0.32 (2.31%) suggests moderate volatility. From a fundamental perspective, the companys Market Cap stands at $457.03M USD, with a Forward P/E of 28.25, indicating a relatively high valuation. The negative RoE of -4.94% raises concerns about the companys profitability.

Forecasting CCRNs future performance, we can expect the stock to face resistance around the $14.77 level, based on the 50-day SMA. If the company can demonstrate improved profitability and revenue growth, it may attract more investors, driving the stock price higher. However, if the negative RoE persists, it may continue to weigh on the stocks performance. Based on the current technical and fundamental data, a potential price target for CCRN could be around $16.50, representing a 17% upside from current levels. However, this forecast is contingent on the companys ability to address its profitability concerns and demonstrate sustainable growth.